SUVRETTA CAPITAL MANAGEMENT, LLC Q2 2021 Filing
Filed August 16, 2021
Portfolio Value
$6.7T
Holdings
121
Report Date
Q2 2021
Filing Type
13F-HR
All Holdings (121 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | —CLIMATE CHANGE CRISIS REAL I | 200,000 | $3.0B | 0.04% | |
| 102 | —OMEGA ALPHA SPAC | 300,000 | $3.0B | 0.04% | |
| 103 | —HEALTHCOR CATALIO ACQU CORP | 300,000 | $3.0B | 0.04% | |
| 104 | —EUROPEAN BIOTECH ACQUTN CORP | 300,000 | $2.9B | 0.04% | |
| 105 | ADAGADAGENE INC | 204,000 | $2.8B | 0.04% | |
| 106 | —CANO HEALTH INC | 674,566 | $2.5B | 0.04% | |
| 107 | —DECIBEL THERAPEUTICS INC | 263,600 | $2.3B | 0.03% | |
| 108 | —BCLS ACQUISITION CORP | 200,000 | $2.1B | 0.03% | |
| 109 | —TURMERIC ACQUISITION CORP | 200,000 | $2.0B | 0.03% | |
| 110 | SANASANA BIOTECHNOLOGY INC | 100,000 | $2.0B | 0.03% | |
| 111 | —FOLEY TRASIMENE ACQUISTN COR | 774,375 | $1.6B | 0.02% | |
| 112 | —ELLIOTT OPPORTUNITY II CORP | 150,000 | $1.5B | 0.02% | |
| 113 | —ARYA SCIENCES ACQU CORP IV | 100,000 | $1.1B | 0.02% | |
| 114 | —EUCRATES BIOMEDICAL ACQU COR | 99,999 | $984.0M | 0.01% | |
| 115 | FHTXFOGHORN THERAPEUTICS INC | 84,000 | $896.0M | 0.01% | |
| 116 | —FRAZIER LIFESCIENCES ACQU CO | 87,498 | $854.0M | 0.01% | |
| 117 | —FINSERV ACQUISITION CORP II | 273,149 | $328.0M | 0.00% | |
| 118 | —EUROPEAN BIOTECH ACQUTN CORP | 100,000 | $95.0M | 0.00% | |
| 119 | —TURMERIC ACQUISITION CORP | 66,666 | $61.0M | 0.00% | |
| 120 | —EUCRATES BIOMEDICAL ACQU COR | 33,333 | $35.0M | 0.00% | |
| 121 | —FRAZIER LIFESCIENCES ACQU CO | 29,166 | $32.0M | 0.00% |
PreviousPage 2 of 2